Search clinical trials for: bendamustine hydrochloride
Total 7398 results
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Untreated Adult Acute Myeloid... and other conditionsUnited States
-
University Hospital TuebingenArbeitsgemeinschaft fur Internistische Onkologie; German Sarcoma GroupCompleted
-
Beth ChristianCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Charite University, Berlin, Germanyribosepharm GmbHUnknownRecurrent Small Cell Lung CancerGermany
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
University of ArizonaCephalonCompletedOvarian CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkCompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Medical University of ViennaRecruitingMantle-cell LymphomaAustria
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's LymphomaJapan
-
Novartis PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL) | Leukaemia, Lymphocytic, ChronicUnited States, Belgium, Italy, Greece, Russian Federation, Spain, Poland, Czech Republic
-
CephalonCompletedMultiple MyelomaUnited States
-
Meir Medical CenterAssuta Ashdod Hospital; Rabin Medical Center; Tel-Aviv Sourasky Medical Center; Ziv Medical CenterRecruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Jiangsu Simcere Pharmaceutical Co., Ltd.CompletedChronic Lymphocytic LeukemiaChina
-
SymBio PharmaceuticalsCompleted
-
Prof. Dr. Wolfgang HiddemannHoffmann-La Roche; Mundipharma Research GmbH & Co KGCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedIndolent B-Cell Non-Hodgkin's LymphomasChina
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
NYU Langone HealthCephalonTerminated
-
M.D. Anderson Cancer CenterWithdrawnLymphoma | Leukemia
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNeoplasms | Leukemia | Chronic Lymphocytic LeukemiaChina
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedLeukemiaIsrael, United States, Australia, Belarus, Brazil, Canada, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Singapore
-
M.D. Anderson Cancer CenterCephalonTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterCephalonCompletedLymphoma | Hodgkin's DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; CephalonTerminatedBrain MetastasesUnited States
-
Yale UniversityWithdrawnHematopoietic/Lymphoid Cancer | Infectious Mononucleosis | PTLD | Lymphoid Tumor | Plasmacytic Hyperplasia PTLD | Florid Follicular Hyperplasia PTLD | Polymorphic PTLD | Monomorphic PTLD | Classical Hodgkin Lymphoma Type PTLDUnited States
-
UNC Lineberger Comprehensive Cancer CenterCephalonCompletedLymphoma | Diffuse Large B-Cell Lymphoma | Lymphoma, Diffuse Large-Cell | Diffuse Large-Cell LymphomaUnited States
-
CephalonCompleted
-
Kami Maddocks, MDPharmacyclics LLC.Active, not recruitingExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNon-Hodgkin Lymphoma by Clinical CourseChina
-
Cairo UniversityRecruiting
-
German Breast GroupCompleted
-
German CLL Study GroupGilead Sciences; Novartis PharmaceuticalsCompletedChronic Lymphocytic LeukemiaGermany
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Canada, Puerto Rico
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.CompletedT-cell LymphomaFrance
-
WiSP Wissenschaftlicher Service Pharma GmbHMundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbHCompletedChronic Lymphocytic LeukemiaGermany
-
Novartis PharmaceuticalsCompletedLymphoma, Non-HodgkinUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedBendamustine | Conditioning Therapy | Autologous Stem Cell Transplant | Aggressive Non Hodgkin's LymphomaSpain
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL)United States, Austria, Germany, Poland, Spain
-
Columbia UniversityCompletedHodgkin Lymphoma | Anaplastic Large Cell LymphomaCanada, United States